0 results for 'null'
GlaxoSmithKline Seeks to Reinstate $235M Infringement Verdict Against Teva Over Hypertension Drug
GlaxoSmithKline is appealing a Delaware federal district judge's ruling that wiped out a $235 million verdict against Teva Pharmaceuticals for allegedly infringing a patent for the hypertension drug Coreg.Glasscock Greenlights Contract Claims in Suit Over Diverted Bid Rights
The Delaware Court of Chancery has allowed breach of contract claims to proceed against the manager of a Delaware LLC accused of diverting the firm's assets to benefit himself and his friends.Glasscock Ruling Bolsters Former Energy Execs' Case for Damages
A Delaware Court of Chancery judge has removed a hurdle for two former executives of Louis Dreyfus Highbridge Energy to pursue potentially millions of dollars in damages stemming from the firm's $1.9 billion sale of its energy storage and processing plants in 2011.Energy Transfer Equity Denied New Hearing in $1.5B Fee Dispute
A vice chancellor of the Delaware Court of Chancery on Monday refused Energy Transfer Equity's bid for a second chance at claiming a nearly $1.5 billion break-up fee stemming from the pipeline company's failed merger with The Williams Cos. Inc.Lord & Taylor Hit With Lawsuit After Data Breach Affected More Than 5 Million Customers
The plaintiff in a proposed class action on Thursday accused high-end retailer Lord & Taylor of negligence in failing to protect its customers' private information, just days after the Hudson's Bay Co. subsidiary announced that it had been the target of a massive data breach in its North American stores.View more book results for the query "*"
What's Really Happening in Securities Litigation? A Tale of Two Bars
Corporate Securities columnist John C. Coffee Jr. writes: Once upon a time, courts might wink and nod at “merger objection” cases and cooperate in their settlement. But with these cases now approaching 50 percent of all securities class actions, this “business-as-usual” approach cannot (and should not) continue. As a result, this may be the best of times for the established plaintiff's bar in securities class actions and the worst of times for the others.Stark Wipes Out $2.5 Billion Verdict in Hep C Drug Patent Case
A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.Derivative Suit Against Twitter Directors Lands in Del.
A derivative suit accusing Twitter Inc.'s directors of insider selling and unjust enrichment landed in Delaware federal court on Monday, after the parties agreed to transfer the case from California.IBM Accuses Expedia of Infringement After Settling With Priceline
IBM Corp. last week added Expedia Inc. and its related travel websites to a list of companies that the tech giant has accused of infringing four patents covering information storage and sign-on technology.Glasscock Tosses Claim to Breakup Fee in Failed Merger
A Delaware Court of Chancery judge on Friday dealt a major blow to Energy Transfer Equity's bid to recover a breakup fee from a failed merger with The Williams Cos. Inc., saying the pipeline company's decision to walk away from the once-promising deal wiped out most of its claims to the $1 billion payment.The Real Estate Leader's Quick Guide: Insights for Better Lease Administration
Brought to you by LeaseAccelerator
Download Now
Your Long-Term Care Legislation Playbook
Brought to you by Trustmark Voluntary Benefits
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
7 Proven Strategies for Implementing a Workers' Comp Cloud Platform
Brought to you by Origami Risk
Download Now